USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
USANA Health Sciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
USANA Health Sciences's pe ratio was 47.0× on Jul 31, 2026, against 16.1× a year earlier. Over the last 5 years it ranged from 11.5× to 47.0×, with a median of 14.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 47.0× | +24.7 |
| 2025 | Dec 31, 2025 | 22.3× | +9.6 |
| 2024 | Dec 31, 2024 | 12.7× | −4.7 |
| 2023 | Dec 29, 2023 | 17.3× | +3.9 |
| 2022 | Dec 30, 2022 | 13.4× | −2.0 |
| 2021 | Dec 31, 2021 | 15.4× | +1.2 |
| 2020 | Dec 31, 2020 | 14.3× | −3.9 |
| 2019 | Dec 31, 2019 | 18.1× | −15.0 |
| 2018 | Dec 31, 2018 | 33.2× | +12.8 |
| 2017 | Dec 29, 2017 | 20.4× | +5.3 |
| 2016 | Dec 30, 2016 | 15.1× | −3.1 |
| 2015 | Dec 31, 2015 | 18.3× | −0.8 |
| 2014 | Dec 31, 2014 | 19.0× | +5.1 |
| 2013 | Dec 31, 2013 | 13.9× | +5.8 |
| 2012 | Dec 31, 2012 | 8.1× | −1.5 |
| 2011 | Dec 30, 2011 | 9.6× | −10.4 |
| 2010 | Dec 31, 2010 | 20.0× | – |
See a number that looks wrong?